BioCentury | May 4, 2019
Product Development
Amyloid: how did we get here and what can we learn?
...long.” Merck has a tau PET imaging agent, and licensed a preclinical anti-tau antibody from Teijin Pharma Ltd....
...Inc. (NYSE:PFE), New York, N.Y. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Rodin Therapeutics Inc., Cambridge, Mass. Teijin Pharma Ltd....
...Inc. (NYSE:PFE), New York, N.Y. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Rodin Therapeutics Inc., Cambridge, Mass. Teijin Pharma Ltd....